News Tag: Staff change - Page 2

XVIVO appoints a new IP manager and a new Medical Director

  • 13:40

Anne-Li Sigvardsson, MSc has been appointed Chief Intellectual Property Officer (CIPO). Anne-Li is responsible for the company’s IP portfolio and has developed XVIVO’s patent portfolio for PrimECC and Perfadex Plus, among other products. Andreas Wallinder, MD, PhD has been appointed Chief Medical Officer (CMO). Andreas is the indication leader for the company’s heart preservation development and also clinically responsible within the company.

Read more

XVIVO förstärker ledningsgruppen

  • 07:30

För att säkerhetsställa en fortsatt god utveckling av XVIVO Perfusion förstärks ledningsgruppen. Karin Fischer, tillträder som Sälj- och Marknadsdirektör Americas och Pär-Ola Larsson, tillträder som Sälj- och Marknadsdirektör EMEA, har rekryterats utifrån. Emur Jensen, Utvecklingschef och Jenny Wennerberg, Kvalitetschef har varit anställda av XVIVO Perfusion i tre respektive två år.

Read more

XVIVO strengthens management team

  • 07:30

XVIVO Perfusion’s management team is being strengthened in order to ensure a continued good development of the company. Karin Fischer, who assumes the position of Marketing and Sales Director Americas, and Pär-Ola Larsson, who assumes the position of Marketing and Sales Director EMEA, have been recruited externally. Emur Jensen, Director of Development, and Jenny Wennerberg, Director of Quality, have been employees at XVIVO Perfusion for three and two years, respectively.

Read more